Barely Significant
← all excerpts

Beyond taxanes: the next generation of microtubule-targeting agents.

Breast Cancer Res Treat · 2012 · PMC3387492 · PMID 22113255

1
hedged sentence
0.1370
closest p · 2.7× alpha
0.1370
boldest claim

The sentences

showed a trendP = 0.137not close (p > 0.1)
5%; P = 0.002) and showed a trend for improving PFS (3.7 vs. 2.2 months; P = 0.137).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.